Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: A case report

Amyloid

Volumn 22, Issue 3, 2015, Pages 203-204

  Kon, Tomoya ^a   Misumi, Yohei ^b   Nishijima, Haruo ^a   Honda, Masaki ^b   Suzuki, Chieko ^a   Baba, Masayuki ^a   Inomata, Yukihiro ^b   Obayashi, Konen ^c   Ando, Yukio ^b   Tomiyama, Masahiko ^a  

^a AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cardiac amyloidosis; familial amyloid polyneuropathy; Leu55Pro mutation; liver transplantation; tafamidis; transthyretin

Indexed keywords

CONGO RED; IMMUNOGLOBULIN; PREALBUMIN; SERUM ALBUMIN; TAFAMIDIS; BENZOXAZOLE DERIVATIVE; NEUROPROTECTIVE AGENT;

ABDOMINAL DISCOMFORT; ACHILLES REFLEX; ADULT; AMYLOIDOSIS; ANHIDROSIS; AREFLEXIA; AUTONOMIC DYSFUNCTION; BODY MASS; BODY WEIGHT; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONSTIPATION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; ELECTROMYOGRAM; ENDOSCOPIC BIOPSY; ERECTILE DYSFUNCTION; FAINTNESS; FOLLOW UP; GENE MUTATION; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE WALL; HEART VENTRICLE EXTRASYSTOLE; HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPESTHESIA; IMMUNOHISTOCHEMISTRY; JAPANESE (PEOPLE); LEG PAIN; LETTER; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; MUSCLE WEAKNESS; MYOCARDIAL PERFUSION IMAGING; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NEUROLOGIC EXAMINATION; ORTHOSTATIC HYPOTENSION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RECTUM BIOPSY; SENSORY NERVE; SYMPATHETIC NERVE; URINE INCONTINENCE; WHEELCHAIR; AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHIES, FAMILIAL; CHEMISTRY; COMPLICATION; GENETICS; MUTATION; PATHOLOGY;

ADULT; AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHIES, FAMILIAL; BENZOXAZOLES; HUMANS; HYPESTHESIA; LIVER TRANSPLANTATION; MALE; MUSCLE WEAKNESS; MUTATION; NEUROPROTECTIVE AGENTS; PREALBUMIN;

EID: 84940034259     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2015.1031373     Document Type: Letter

References (6)

1. Jacobson DR, McFarlin DE, Kane I, Buxbaum JN. Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 1992;89:353-6.
2. Yamamoto K, Hsu SP, Yoshida K, Ikeda S, Nakazato M, Shiomi K, Cheng SY, et al. Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55-4Pro). Muscle Nerve 1994;17:637-41.
3. Quintas A, Vaz DC, Cardoso I, Saraiva MJ. Brito RM. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 2001;276:27207-13.
4. Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener 2014;3:19.
5. Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, et al. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. J Neurol Neurosurg Psychiatry 2014;85:740-6.
6. Coelho T, Maia LF, da Silva AM, Cruz MW, Planté-Bordeneuve V, Suhr OB, Conceiçao I, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol 2013;260:2802-14.